August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Stephen V Liu: Some guidance on the management of adverse events with sotorasib in KRAS G12C NSCLC Lung Cancer Journal
Apr 13, 2024, 12:35

Stephen V Liu: Some guidance on the management of adverse events with sotorasib in KRAS G12C NSCLC Lung Cancer Journal

Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared a post on X:

Some guidance on the management of adverse events with sotorasib in KRAS G12C NSCLC Lung Cancer Journal. Most common grade 2+ adverse events were diarrhea and hepatotoxicity, esp if given after immunotherapy. Close monitoring and dose modification important.

Read further.
Source: Stephen V Liu/X